APA (7th ed.) Citation

Chari, A., & Raab, M. (2019). Oral selinexor-dexamethasone for triple-class refractory multiple myeloma. The New England journal of medicine, 381(8), . https://doi.org/10.1056/NEJMoa1903455

Chicago Style (17th ed.) Citation

Chari, Ajai, and Marc-Steffen Raab. "Oral Selinexor-dexamethasone for Triple-class Refractory Multiple Myeloma." The New England Journal of Medicine 381, no. 8 (2019). https://doi.org/10.1056/NEJMoa1903455.

MLA (9th ed.) Citation

Chari, Ajai, and Marc-Steffen Raab. "Oral Selinexor-dexamethasone for Triple-class Refractory Multiple Myeloma." The New England Journal of Medicine, vol. 381, no. 8, 2019, https://doi.org/10.1056/NEJMoa1903455.